Skip to main content

Table 4 Distribution of isolates across the centres

From: High prevalence of resistance to third-generation cephalosporins detected among clinical isolates from sentinel healthcare facilities in Lagos, Nigeria

Sentinel centres

No of patients with request for culture within the study period

No of patients who consented and participated in the study

No of isolates obtained

MDR prevalence (%)

X2 = 5.47

P = 0.49

LIMH

402

140 (34.8%)

36 (25.7%)

29 (80.6)

MGH

302

143(47.4%)

113 (79%)

88 (77.6)

RGH

330

125 (37.8%)

38 (30.4%)

29 (76.3)

SGH

691

91 (13.2%)

45 (49.5%)

38 (84.4)

Total

1725

499

232 (46.5%)

184 (79.3)